Tizepatide is a weekly injection that activates the GIP and GLP-1 receptors in the body. These receptors regulate appetite, insulin, and glucagon levels as well as satiety and gastric emptying.

Tirzepatide injections are given over a 16-20 week time period and the dose of the medication is titrated up as you go. Tirzepatide is a weight-loss alternative and patients should expect to be committed for at least 3 months. Tirzepatide patients can expect to lose anywhere from 12-22% of body weight.